These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26235450)

  • 1. The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.
    Charidimou A; Wilson D; Shakeshaft C; Ambler G; White M; Cohen H; Yousry T; Al-Shahi Salman R; Lip G; Houlden H; Jäger HR; Brown MM; Werring DJ
    Int J Stroke; 2015 Oct; 10 Suppl A100():155-61. PubMed ID: 26235450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
    Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
    Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology.
    Poggesi A; Barbato C; Galmozzi F; Camilleri E; Cesari F; Chiti S; Diciotti S; Galora S; Giusti B; Gori AM; Marzi C; Melone A; Mistri D; Pescini F; Pracucci G; Rinnoci V; Sarti C; Fainardi E; Marcucci R; Salvadori E
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31548494
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
    Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
    Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.
    Marques-Matos C; Alves JN; Marto JP; Ribeiro JA; Monteiro A; Araújo J; Silva F; Grenho F; Viana-Baptista M; Sargento-Freitas J; Pinho J; Azevedo E
    Int J Stroke; 2017 Aug; 12(6):623-627. PubMed ID: 27903938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
    Shiozawa M; Koga M; Inoue H; Yamashita T; Yasaka M; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Nakahara J; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T; Toyoda K
    Int J Stroke; 2023 Oct; 18(8):986-995. PubMed ID: 37154598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds.
    Badi MK; Vilanilam GK; Gupta V; Barrett KM; Lesser ER; Cochuyt JJ; Hodge DO; Brott TG; Meschia JF
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2159-2167. PubMed ID: 31103554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
    Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
    Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk.
    Charidimou A; Shakeshaft C; Werring DJ
    Front Neurol; 2012; 3():133. PubMed ID: 23015806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation.
    Soo Y; Zietz A; Yiu B; Mok VCT; Polymeris AA; Seiffge D; Ambler G; Wilson D; Leung TWH; Tsang SF; Chu W; Abrigo J; Cheng C; Lee KJ; Lim JS; Shiozawa M; Koga M; Chabriat H; Hennerici M; Wong YK; Mak H; Collet R; Inamura S; Yoshifuji K; Arsava EM; Horstmann S; Purrucker J; Lam BYK; Wong A; Kim YD; Song TJ; Lemmens R; Eppinger S; Gattringer T; Uysal E; Demirelli DS; Bornstein NM; Assayag EB; Hallevi H; Molad J; Nishihara M; Tanaka J; Coutts SB; Kappelle LJ; Al-Shahi Salman R; Jager R; Lip GYH; Goeldlin MB; Panos LD; Mas JL; Legrand L; Karayiannis C; Phan T; Bellut M; Chappell F; Makin S; Hayden D; Williams D; van Dam-Nolen DHK; Nederkoorn PJ; Barbato C; Browning S; Wiegertjes K; Tuladhar AM; Mendyk AM; Köhler S; van Oostenburgge R; Zhou Y; Xu C; Hilal S; Gyanwali B; Chen C; Lou M; Staals J; Bordet R; Kandiah N; de Leeuw FE; Simister R; Hendrikse J; Wardlaw J; Kelly P; Fluri F; Srikanth V; Calvet D; Jung S; Kwa VIH; Smith EE; Hara H; Yakushiji Y; Orken DN; Fazekas F; Thijs V; Heo JH; Veltkamp R; Ay H; Imaizumi T; Lau KK; Jouvent E; Toyoda K; Yoshimura S; Bae HJ; Martí-Fàbregas J; Prats-Sánchez L; Lyrer P; Best J; Werring D; Engelter ST; Peters N;
    Ann Neurol; 2023 Jul; 94(1):61-74. PubMed ID: 36928609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
    Giustozzi M; Acciarresi M; Agnelli G; Caso V; Bandini F; Tsivgoulis G; Yaghi S; Furie KL; Tadi P; Becattini C; Zedde M; Abdul-Rahim AH; Lees KR; Alberti A; Venti M; D'Amore C; Giulia Mosconi M; Anna Cimini L; Bovi P; Carletti M; Rigatelli A; Cappellari M; Putaala J; Tomppo L; Tatlisumak T; Marcheselli S; Pezzini A; Poli L; Padovani A; Vannucchi V; Sohn SI; Lorenzini G; Tassi R; Guideri F; Acampa M; Martini G; Ntaios G; Athanasakis G; Makaritsis K; Karagkiozi E; Vadikolias K; Liantinioti C; Theodorou A; Halvatsiotis P; Mumoli N; Galati F; Sacco S; Tiseo C; Corea F; Ageno W; Bellesini M; Silvestrelli G; Ciccone A; Lanari A; Scoditti U; Denti L; Mancuso M; Ferrari E; Ulivi L; Orlandi G; Giannini N; Tassinari T; Luisa De Lodovici M; Rueckert C; Baldi A; Toni D; Letteri F; Giuntini M; Maria Lotti E; Flomin Y; Pieroni A; Kargiotis O; Karapanayiotides T; Monaco S; Maimone Baronello M; Csiba L; Szabó L; Chiti A; Giorli E; Del Sette M; Imberti D; Zabzuni D; Doronin B; Volodina V; Michel P; Vanacker P; Barlinn K; Barlinn J; Deleu D; Gourbali V; Paciaroni M; Masotti L
    Stroke; 2020 Aug; 51(8):2347-2354. PubMed ID: 32646335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
    Umemura T; Mashita S; Kawamura T
    PLoS One; 2020; 15(9):e0238456. PubMed ID: 32941455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GYH; Larsen TB
    Stroke; 2019 Apr; 50(4):939-946. PubMed ID: 30869568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
    Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
    Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
    Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
    Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Narrative Review of Nonvitamin K Antagonist Oral Anticoagulant Use in Secondary Stroke Prevention.
    Caso V; Masuhr F
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2363-2375. PubMed ID: 31281110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.